Call for collaborative research proposals
Schrödinger’s therapeutics group is inviting proposals from the academic community for innovative approaches to target and treat human diseases with small molecule drugs. Our industry-leading computational platform, coupled with our scientific expertise in drug discovery, can facilitate the rapid acceleration of your discoveries and hypotheses to the clinical development candidate stage.
The goal of this Request for Proposals (RFP) is to support translational research from breakthrough academic research, which has identified novel and differentiated drug targets for the treatment of diseases with clear unmet needs. This funding mechanism enables the advancement of novel and validated drug targets discovered in academia and for which academic researchers lack adequate resources or expertise for drug discovery and development.
Learn more about the collaborative research opportunity